Q3 2024 Holdings
Filed 2024-11-13 | 112 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $140.6M | 2,969,733 | 7.0% |
| Beigene Ltd(ONC) | SPONSORED ADR | 07725L102 | $126.5M | 563,314 | 6.3% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $90.2M | 11,259,438 | 4.5% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $78.3M | 3,072,827 | 3.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $77.9M | 143,647 | 3.9% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $66.9M | 1,309,652 | 3.3% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $66.2M | 1,440,736 | 3.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $62.5M | 2,167,224 | 3.1% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $61.1M | 38,918,903 | 3.1% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $55.1M | 3,330,422 | 2.8% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $52.1M | 3,258,677 | 2.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $51.9M | 347,921 | 2.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $51.5M | 2,831,770 | 2.6% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $47.6M | 2,458,778 | 2.4% |
| Wave Life Sciences Ltd(WVE) | SHS | Y95308105 | $46.9M | 5,721,172 | 2.3% |
| SpringWorks Therapeutics Inc | COM | 85205L107 | $44.1M | 1,377,701 | 2.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $40.8M | 1,134,664 | 2.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $37.0M | 837,928 | 1.9% |
| Neumora Therapeutics Inc(NMRA) | COM | 640979100 | $34.4M | 2,606,571 | 1.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $34.3M | 299,991 | 1.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $34.2M | 753,601 | 1.7% |
| Merus NV | COM | N5749R100 | $34.1M | 682,201 | 1.7% |
| Taboola.com Ltd(TBLA) | ORD SHS | M8744T106 | $33.5M | 9,969,495 | 1.7% |
| Longboard Pharmaceuticals Inc | COM | 54300N103 | $30.1M | 903,227 | 1.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $29.3M | 743,769 | 1.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $27.8M | 525,971 | 1.4% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $26.2M | 1,339,942 | 1.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $24.6M | 1,612,077 | 1.2% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $24.3M | 834,028 | 1.2% |
| Erasca Inc(ERAS) | COM | 29479A108 | $24.2M | 8,857,179 | 1.2% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $20.3M | 1,211,357 | 1.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $20.1M | 2,603,897 | 1.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $19.2M | 2,749,041 | 1.0% |
| Prothena Corporation PLC(PRTA) | SHS | G72800108 | $18.4M | 1,099,840 | 0.9% |
| NewAmsterdam Pharma Company NV(NAMS) | ORDINARY SHARES | N62509109 | $15.3M | 920,564 | 0.8% |
| Biohaven Ltd(BHVN) | COM | G1110E107 | $14.2M | 283,540 | 0.7% |
| Korro Bio Inc(KRRO) | COM | 500946108 | $14.0M | 418,833 | 0.7% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $13.9M | 1,633,768 | 0.7% |
| Gossamer Bio Inc(GOSS) | COM | 38341P102 | $13.1M | 13,281,610 | 0.7% |
| Instil Bio Inc(TIL) | COM NEW | 45783C200 | $13.0M | 192,433 | 0.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $10.8M | 404,113 | 0.5% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $10.4M | 1,106,040 | 0.5% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $10.3M | 1,007,575 | 0.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $10.0M | 250,000 | 0.5% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $9.8M | 4,879,875 | 0.5% |
| Microsoft Corp(MSFT) | COM | 594918104 | $9.5M | 22,000 | 0.5% |
| Cartesian Therapeutics Inc(RNAC) | COM NEW | 816212302 | $9.2M | 572,236 | 0.5% |
| Acelyrin Inc | COM | 00445A100 | $8.5M | 1,729,665 | 0.4% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $8.3M | 460,753 | 0.4% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $7.9M | 4,000,000 | 0.4% |